Try a new search

Format these results:

Searched for:

in-biosketch:true

person:husais06

Total Results:

172


Discrepant creatinine- versus cystatin C-based kidney function estimates in pediatric heart and liver transplant recipients [Letter]

Lipman, Amy R; Husain, Syed Ali
PMCID:11917520
PMID: 38557874
ISSN: 1432-198x
CID: 5866822

Cold Ischemia Time and Delayed Graft Function in Kidney Transplantation: A Paired Kidney Analysis

Husain, Syed Ali; Khanna, Sohil; Yu, Miko; Adler, Joel T; Cron, David C; King, Kristen L; Schold, Jesse D; Mohan, Sumit
BACKGROUND:We aimed to understand the association between cold ischemia time (CIT) and delayed graft function (DGF) after kidney transplantation and the impact of organ pumping on that association. METHODS:Retrospective cohort study using US registry data. We identified kidney pairs from the same donor where both kidneys were transplanted but had a CIT difference >0 and ≤20 h. We determined the frequency of concordant (both kidneys with/without DGF) or discordant (only 1 kidney DGF) DGF outcomes. Among discordant pairs, we computed unadjusted and adjusted relative risk of DGF associated with longer-CIT status, when then repeated this analysis restricted to pairs where only the longer-CIT kidney was pumped. RESULTS:Among 25 831 kidney pairs included, 71% had concordant DGF outcomes, 16% had only the longer-CIT kidney with DGF, and 13% had only the shorter-CIT kidney with DGF. Among discordant pairs, longer-CIT status was associated with a higher risk of DGF in unadjusted and adjusted models. Among pairs where only the longer-CIT kidney was pumped, longer-CIT kidneys that were pumped had a lower risk of DGF than their contralateral shorter-CIT kidneys that were not pumped regardless of the size of the CIT difference. CONCLUSIONS:Most kidney pairs have concordant DGF outcomes regardless of CIT difference, but even small increases in CIT raise the risk of DGF. Organ pumping may mitigate and even overcome the adverse consequences of prolonged CIT on the risk of DGF, but prospective studies are needed to better understand this relationship.
PMCID:11338744
PMID: 38557641
ISSN: 1534-6080
CID: 5866812

Association between donor kidney cysts and donor and recipient outcomes after living donor kidney transplantation

Emmons, Brendan R; Adler, Joel T; Sandoval, Pedro Rodrigo; King, Kristen L; Yu, Miko; Cron, David C; Mohan, Sumit; Ratner, Lloyd E; Husain, Syed Ali
INTRODUCTION:Incidental kidneys cysts are typically considered benign, but the presence of cysts is more frequent in individuals with other early markers of kidney disease. We studied the association of donor kidney cysts with donor and recipient outcomes after living donor kidney transplantation. METHODS:We retrospective identified 860 living donor transplants at our center (1/1/2011-7/31/2022) without missing data. Donor cysts were identified by review of pre-donation CT scan reports. We used linear regression to study the association between donor cysts and 6-month single-kidney estimated glomerular filtration rate (eGFR) increase, and time-to-event analyses to study the association between donor cysts and recipient death-censored graft failure. RESULTS:Among donors, 77% donors had no kidney cysts, 13% had ≥1 cyst on the kidney not donated, and 11% only had cysts on the donated kidney. In adjusted linear regression, cysts on the donated kidney and kidney not donated were not significantly associated with 6-month single-kidney eGFR increase. Among transplants, 17% used a transplanted kidney with a cyst and 6% were from donors with cysts only on the kidney not transplanted. There was no association between donor cyst group and post-transplant death-censored graft survival. Results were similar in sensitivity analyses comparing transplants using kidneys with no cysts versus 1-2 cysts versus ≥3 cysts. CONCLUSIONS:Kidney cysts in living kidney donors were not associated with donor kidney recovery or recipient allograft longevity, suggesting incidental kidney cysts need not be taken into account when determining living donor candidate suitability or the laterality of planned donor nephrectomy.
PMCID:11930354
PMID: 38289895
ISSN: 1399-0012
CID: 5866792

Association of Implantation Biopsy Findings in Living Donor Kidneys With Donor and Recipient Outcomes

Emmons, Brendan R; Batal, Ibrahim; King, Kristen L; Yu, Miko; Canetta, Pietro A; Sandoval, P Rodrigo; Mohan, Sumit; Tsapepas, Demetra; Adler, Joel T; Ratner, Lloyd E; Husain, S Ali
RATIONALE & OBJECTIVE:Some living donor kidneys are found to have biopsy evidence of chronic scarring and/or glomerular disease at implantation, but it is unclear if these biopsy findings help predict donor kidney recovery or allograft outcomes. Our objective was to identify the prevalence of chronic histological changes and glomerular disease in donor kidneys, and their association with donor and recipient outcomes. STUDY DESIGN:Retrospective cohort study. SETTING & PARTICIPANTS:Single center, living donor kidney transplants from January 2010 to July 2022. EXPOSURE:Chronic histological changes, glomerular disease in donor kidney implantation biopsies. OUTCOME:at 6 months after donation; for recipients, death-censored allograft survival. ANALYTICAL APPROACH:Biopsies were classified as having possible glomerular disease by pathologist diagnosis or chronic changes based on the percentage of glomerulosclerosis, interstitial fibrosis/tubular atrophy, and vascular disease. We used logistic regression to identify factors associated with the presence of chronic changes, linear regression to identify the association between chronic changes and single-kidney estimated glomerular filtration rate (eGFR) recovery, and time-to-event analyses to identify the relationship between abnormal biopsy findings and allograft outcomes. RESULTS:. There were no differences in time-to-death-censored allograft failure in unadjusted or adjusted Cox proportional hazards models when comparing kidneys with chronic changes to kidneys without histological abnormalities. LIMITATIONS:Retrospective, absence of measured GFR. CONCLUSIONS:Approximately 1 in 7 living donor kidneys had chronic changes on implantation biopsy, primarily in the form of moderate vascular disease, and 1% had possible donor glomerular disease. Abnormal implantation biopsy findings were not significantly associated with 6-month donor eGFR outcomes or allograft survival. PLAIN-LANGUAGE SUMMARY:Kidney biopsies are the gold standard test to identify the presence or absence of kidney disease. However, kidneys donated by healthy living donors-who are extensively screened for any evidence of kidney disease before donation-occasionally show findings that might be considered "abnormal," including the presence of scarring in the kidney or findings suggestive of a primary kidney disease. We studied the frequency of abnormal kidney biopsy findings among living donors at our center. We found that about 14% of kidneys had chronic abnormalities and 1% had findings suggesting possible glomerular kidney disease, but the presence of abnormal biopsy findings was not associated with worse outcomes for the donors or their recipients.
PMID: 37879529
ISSN: 1523-6838
CID: 5866782

The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts

Roufosse, Candice; Naesens, Maarten; Haas, Mark; Lefaucheur, Carmen; Mannon, Roslyn B; Afrouzian, Marjan; Alachkar, Nada; Aubert, Olivier; Bagnasco, Serena M; Batal, Ibrahim; Bellamy, Chris O C; Broecker, Verena; Budde, Klemens; Clahsen-Van Groningen, Marian; Coley, Shana M; Cornell, Lynn D; Dadhania, Darshana; Demetris, Anthony J; Einecke, Gunilla; Farris, Alton B; Fogo, Agnes B; Friedewald, John; Gibson, Ian W; Horsfield, Catherine; Huang, Edmund; Husain, Syed A; Jackson, Annette M; Kers, Jesper; Kikić, Željko; Klein, Amanda; Kozakowski, Nicolas; Liapis, Helen; Mangiola, Massima; Montgomery, Robert A; Nankinvell, Brian; Neil, Desley A H; Nickerson, Peter; Rabant, Marion; Randhawa, Parmjeet; Riella, Leonardo V; Rosales, Ivy; Royal, Virginie; Sapir-Pichhadze, Ruth; Sarder, Pinaki; Sarwal, Minnie; Schinstock, Carrie; Stegall, Mark; Solez, Kim; van der Laak, Jeroen; Wiebe, Chris; Colvin, Robert B; Loupy, Alexandre; Mengel, Michael
The XVIth Banff Meeting for Allograft Pathology was held in Banff, Alberta, Canada, from September 19 to 23, 2022, as a joint meeting with the Canadian Society of Transplantation. In addition to a key focus on the impact of microvascular inflammation and biopsy-based transcript analysis on the Banff Classification, further sessions were devoted to other aspects of kidney transplant pathology, in particular T cell-mediated rejection, activity and chronicity indices, digital pathology, xenotransplantation, clinical trials, and surrogate endpoints. Although the output of these sessions has not led to any changes in the classification, the key role of Banff Working Groups in phrasing unanswered questions, and coordinating and disseminating results of investigations addressing these unanswered questions was emphasized. This paper summarizes the key Banff Meeting 2022 sessions not covered in the Banff Kidney Meeting 2022 Report paper and also provides an update on other Banff Working Group activities relevant to kidney allografts.
PMCID:11135910
PMID: 37931753
ISSN: 1600-6143
CID: 5722932

Contribution of Estimates of Glomerular Filtration to the Extensive Disparities in Preemptive Listing for Kidney Transplant

King, Kristen L; Yu, Miko; Husain, S Ali; Patzer, Rachel E; Sandra, Vanessa; Reese, Peter P; Schold, Jesse D; Mohan, Sumit
INTRODUCTION/UNASSIGNED:The use of race coefficients in equations for estimated glomerular filtration rate (eGFR) may have contributed to racial disparities in access to preemptive (without dialysis exposure) kidney transplantation (Ktx). METHODS/UNASSIGNED:In this retrospective national cohort study of incident kidney transplant candidates in the United States from 2001 to 2019, we describe temporal trends and racial disparities in preemptive listing and the distribution of eGFR at listing, using eGFR as reported and after removing the race coefficient for Black candidates. RESULTS/UNASSIGNED:). After adjusting for candidate characteristics, including listing eGFR without the race coefficient, preemptive Black candidates still had significantly lower odds of preemptive deceased donor (DD) kidney transplantation compared to non-Black candidates (odds ratio 0.87, 95% confidence interval: 0.78-0.98). CONCLUSIONS/UNASSIGNED:Over the last 2 decades, Black patients were consistently less likely to be listed preemptively and were listed at lower eGFR values. Adjusting for listing eGFR with the race coefficient computationally removed did not eliminate the racial disparity, suggesting that additional efforts are needed to achieve equity in preemptive transplantation beyond adopting race-free eGFR equations.
PMCID:10014377
PMID: 36938099
ISSN: 2468-0249
CID: 5867842

Characterization of Transplant Center Decisions to Allocate Kidneys to Candidates With Lower Waiting List Priority

King, Kristen L; Husain, S Ali; Yu, Miko; Adler, Joel T; Schold, Jesse; Mohan, Sumit
IMPORTANCE:Allocation of deceased donor kidneys is meant to follow a ranked match-run list of eligible candidates, but transplant centers with a 1-to-1 relationship with their local organ procurement organization have full discretion to decline offers for higher-priority candidates and accept them for lower-ranked candidates at their center. OBJECTIVE:To describe the practice and frequency of transplant centers placing deceased donor kidneys with candidates who are not the highest rank at their center according to the allocation algorithm. DESIGN, SETTING, AND PARTICIPANTS:This retrospective cohort study used 2015 to 2019 organ offer data from US transplant centers with a 1-to-1 relationship with their local organ procurement organization, following candidates for transplant events from January 2015 to December 2019. Participants were deceased kidney donors with a single match-run and at least 1 kidney transplanted locally and adult, first-time, kidney-only transplant candidates receiving at least 1 offer for a locally transplanted deceased donor kidney. Data were analyzed from March 1, 2022 to March 28, 2023. EXPOSURE:Demographic and clinical characteristics of donors and recipients. MAIN OUTCOMES AND MEASURES:The outcome of interest was kidney transplantation into the highest-priority candidate (defined as transplanted after zero declines for local candidates in the match-run) vs a lower-ranked candidate. RESULTS:This study assessed 26 579 organ offers from 3136 donors (median [IQR] age, 38 [25-51] years; 2903 [62%] men) to 4668 recipients. Transplant centers skipped their highest-ranked candidate to place kidneys further down the match-run for 3169 kidneys (68%). These kidneys went to a median (IQR) of the fourth- (third- to eighth-) ranked candidate. Higher kidney donor profile index (KDPI; higher score indicates lower quality) kidneys were less likely to go to the highest-ranked candidate, with 24% of kidneys with KDPI of at least 85% going to the top-ranked candidate vs 44% of KDPI 0% to 20% kidneys. When comparing estimated posttransplant survival (EPTS) scores between the skipped candidates and the ultimate recipients, kidneys were placed with recipients with both better and worse EPTS than the skipped candidates, across all KDPI risk groups. CONCLUSIONS AND RELEVANCE:In this cohort study of local kidney allocation at isolated transplant centers, we found that centers frequently skipped their highest-priority candidates to place kidneys further down the allocation prioritization list, often citing organ quality concerns but placing kidneys with recipients with both better and worse EPTS with nearly equal frequency. This occurred with limited transparency and highlights the opportunity to improve the matching and offer algorithm to improve allocation efficiency.
PMCID:10242426
PMID: 37273203
ISSN: 2574-3805
CID: 5867892

Right-Sizing Multiorgan Allocation Involving Kidneys

Husain, S Ali; Hippen, Benjamin; Singh, Neeraj; Parsons, Ronald F; Bloom, Roy D; Anand, Prince Mohan; Lentine, Krista L
PMCID:10637446
PMID: 37379084
ISSN: 1555-905x
CID: 5867902

Effects of Delayed Graft Function on Transplant Outcomes: A Meta-analysis

Li, Miah T; Ramakrishnan, Adarsh; Yu, Miko; Daniel, Emily; Sandra, Vanessa; Sanichar, Navin; King, Kristen L; Stevens, Jacob S; Husain, S Ali; Mohan, Sumit
Delayed graft function (DGF) is a frequent complication of kidney transplantation, but its impact on long- and short-term transplant outcomes is unclear. We conducted a systematic literature search for studies published from 2007 to 2020 investigating the association between DGF and posttransplant outcomes. Forest plots stratified between center studies and registry studies were created with pooled odds ratios. Posttransplant outcomes including graft failure, acute rejection, patient mortality, and kidney function were analyzed. Of the 3422 articles reviewed, 38 papers were included in this meta-analysis. In single-center studies, patients who experienced DGF had increased graft failure (odds ratio [OR] 3.38; 95% confidence interval [CI], 1.85-6.17; P < 0.01), acute allograft rejection (OR 1.84; 95% CI, 1.30-2.61; P < 0.01), and mortality (OR 2.32; 95% CI, 1.53-3.50; P < 0.01) at 1-y posttransplant. Registry studies showed increased graft failure (OR 3.66; 95% CI, 3.04-4.40; P < 0.01) and acute rejection (OR 3.24; 95% CI, 1.88-5.59; P < 0.01) but not mortality (OR 2.27; 95% CI, 0.97-5.34; P = 0.06) at 1-y posttransplant. DGF was associated with increased odds of graft failure, acute rejection, and mortality. These results in this meta-analysis could help inform the selection process, treatment, and monitoring of transplanted kidneys at high risk of DGF.
PMCID:9835896
PMID: 36700066
ISSN: 2373-8731
CID: 5867832

Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort [Letter]

Emmons, Brendan R; Batal, Ibrahim; Radhakrishnan, Jai; Husain, S Ali
PMCID:10524544
PMID: 37244474
ISSN: 1523-1755
CID: 5867882